Acrivon Therapeutics Inc.... (ACRV)
NASDAQ: ACRV
· Real-Time Price · USD
1.38
-0.01 (-0.72%)
At close: Aug 15, 2025, 11:56 AM
-0.72% (1D)
| Bid | 1.34 |
| Market Cap | 43.11M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -83.75M |
| EPS (ttm) | -2.24 |
| PE Ratio (ttm) | -0.61 |
| Forward PE | -0.53 |
| Analyst | Buy |
| Ask | 1.39 |
| Volume | 109,875 |
| Avg. Volume (20D) | 435,708 |
| Open | 1.39 |
| Previous Close | 1.39 |
| Day's Range | 1.34 - 1.43 |
| 52-Week Range | 1.05 - 10.16 |
| Beta | 1.67 |
About ACRV
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ACRV
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ACRV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
-17.59%
ACRV stock has given up its prior gain. Acrivion T...
Unlock content with
Pro Subscription
3 months ago
-17.59%
Acrivion Therapeutics shares are trading higher after the company announced it will present data from its analysis of ACR-2316.
